期刊文献+

细胞凋亡与肥胖相关的非酒精性脂肪性肝病 被引量:4

下载PDF
导出
摘要 近年来,肥胖相关的非酒精性脂肪性肝病的发病率呈上升趋势,并严重影响着人们的健康。其中细胞凋亡及其相关因素肿瘤坏死因子-α,Fas系统,核因子-κB及组织蛋白酶B在肥胖相关的非酒精性脂肪性肝病的发病机制中起了重要的作用。本文概括综述细胞凋亡与其相关因素在肥胖相关的非酒精性脂肪性肝病中的作用。
作者 刘会领 陆伟
出处 《实用肝脏病杂志》 CAS 2007年第2期142-144,共3页 Journal of Practical Hepatology
  • 相关文献

参考文献19

  • 1范建高,朱军,李新建,李锐,戴菲,宋晓敏,陈兰,李锋,陈世耀.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88. 被引量:582
  • 2FELDSTEIN AE,GORES GJ.Apoptosis in alcoholic and nonalcoholic steatohepatitis[J].Front Biosci,2005,10:3093-9.
  • 3LI P,NIJHAWAN D,BUDIHARDJO I,et al.Cytochrome C and d ATP-dependent formation of Apaf/caspase-9 complex initiates an apoptotic protease cascade[J].Cell,1997,91:479-489.
  • 4ZOU H,LI Y,LIU X,et al.An Apaf-1,cytochrome Cmultimeric complex is a functional apoptosome that activates'procaspase-9[J].J Biol Chem,1999,24:11549-56.
  • 5FELDSTEIN AE,CANBAY A,ANGULO P,et al.Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis[J].Gastroenterology,2003,125:437-43.
  • 6FELDSTEIN AE,CANBAY A,GUICCIARDI ME,et al.Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice[J].J Hepatol,2003,39(6):978-83.
  • 7史洪涛,陈东风,李陶,熊仁平.Caspase 3在大鼠非酒精性脂肪肝形成中的作用[J].中华消化杂志,2005,25(3):173-174. 被引量:16
  • 8RAMALHO RM,CORTEZ-PINTO H,CASTRO RE,et al.Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis[J].Eur J Gastroenterol Hepatol,2006,18(1):21-9.
  • 9SALAH M,AOUAD L Y,COHE N,et al.Caspase-3 is a component of fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during fas-mediated cell death[J].J Immunol,2004,172:2316-23.
  • 10PAULOS S,RIBEIRO PS,CORTEZ PINTO H,et al.Hepatocyte apoptosis,expression of death receptors and activation of NF-кB in the liver of nonalcoholic and alcoholic steastohepatitis patients[J].Am J Gastroenterol,2004,99:1708-17.

二级参考文献18

  • 1范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 2Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250.
  • 3Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
  • 4Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
  • 5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
  • 6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
  • 7Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology, 2003,125 : 437-443.
  • 8Feldstein AE, Canbay A, Guicciardi ME, et al. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. JHepatol, 2003,39: 978 983.
  • 9Rust C, Gores GJ. Apoptosis and liver disease. Am J Med,2000,108: 567-574.
  • 10Benedetti A, Marucci L. The significance of apoptosis in the liver. Liver, 1999,19 : 453-463.

共引文献596

同被引文献56

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部